8-K
Current Report
LEXICON PHARMACEUTICALS, INC. Filed Acc 0001062822-14-000002
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading form8-k01132014.htm…